This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.80% per year. These returns cover a period from January 1, 1988 through August 3, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Will Escalating Expenses Affect Virtu Financial's Q3 Earnings?
by Zacks Equity Research
VIRT's Q3 results are likely to show gains from higher net trading income, but rising operating costs may pressure margins.
Is a Beat in the Cards for Prudential Financial This Earnings Season?
by Zacks Equity Research
PRU's third-quarter results are likely to reflect higher net investment spread, favorable underwriting results, and positive net flows.
What's in the Cards for Everest Group This Earnings Season?
by Zacks Equity Research
EG's Q3 results are likely to reflect higher retention, higher assets under management, rate increases, and exposure growth, offset by higher expenses.
Will A Strong Personal Insurance Unit Aid The Hartford's Q3 Earnings?
by Zacks Equity Research
HIG's Q3 results are likely to get a boost from Personal Insurance and Employee Benefits units' growth, but rising costs could weigh on margins.
Prudential (PRU) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Prudential (PRU) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Prudential (PRU) is a Great Dividend Stock Right Now
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Prudential (PRU) have what it takes? Let's find out.
These 2 Finance Stocks Could Beat Earnings: Why They Should Be on Your Radar
by Zacks Equity Research
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Will Prudential (PRU) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Prudential (PRU) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Do Options Traders Know Something About Prudential Financial Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to CorMedix (CRMD) stock based on the movements in the options market lately.
Prudential (PRU) Could Be a Great Choice
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Prudential (PRU) have what it takes? Let's find out.